Back to Search
Start Over
Reducing the hidden burden of severe asthma: Recognition and referrals from primary practice
- Source :
- Journal of Asthma, Journal of Asthma, Informa Healthcare, 2020, ⟨10.1080/02770903.2020.1759084⟩, Journal of Asthma, 2020, ⟨10.1080/02770903.2020.1759084⟩
- Publication Year :
- 2020
- Publisher :
- HAL CCSD, 2020.
-
Abstract
- International audience; Since their introduction many decades ago, systemic corticosteroids have become a mainstay treatment for asthma. Despite being a highly effective therapy, corticosteroids can cause significant adverse effects in patients. This results in a "double hit" for some patients as they suffer the burden of disease as well as the burden of treatment-induced morbidity.This article aims to raise awareness of the potential, harmful side effects of prolonged or repeated exposure to systemic corticosteroids in asthma. It also highlights the importance of referral of the appropriate patients with asthma from primary care for specialist assessment once other considerations such as adherence, inhaler technique and co-morbidity have been evaluated. We propose a simple decision step that may help busy primary care physicians and general practitioners to identify patients who could benefit from specialist assessment.Our decision step suggests that a patient with asthma should be reviewed at least once by an asthma specialist if he/she (i) has received ≥2 courses of oral corticosteroids in the previous year; asthma remains uncontrolled despite good adherence and inhaler technique; or (ii) has attended an emergency department or was hospitalised for asthma care.Such referral could facilitate wider access to diagnostic tools, in-depth assessment of confounding comorbidities, and non-corticosteroid-based therapies as needed, which may be unavailable in primary practice.
- Subjects :
- Pulmonary and Respiratory Medicine
medicine.medical_specialty
Health Knowledge, Attitudes, Practice
decision step process
Referral
specialist
[SDV]Life Sciences [q-bio]
Primary care
Comorbidity
Severity of Illness Index
Medication Adherence
03 medical and health sciences
chemistry.chemical_compound
primary care
0302 clinical medicine
Adrenal Cortex Hormones
medicine
Immunology and Allergy
Humans
030212 general & internal medicine
Intensive care medicine
Adverse effect
Referral and Consultation
Asthma
non-corticosteroid therapy
Primary Health Care
business.industry
Inhaler
Emergency department
Benralizumab
medicine.disease
systemic corticosteroids
3. Good health
[SDV] Life Sciences [q-bio]
030228 respiratory system
chemistry
general practitioner
Pediatrics, Perinatology and Child Health
Chronic Disease
referral
business
Mepolizumab
medicine.drug
Specialization
Subjects
Details
- Language :
- English
- ISSN :
- 02770903 and 15324303
- Database :
- OpenAIRE
- Journal :
- Journal of Asthma, Journal of Asthma, Informa Healthcare, 2020, ⟨10.1080/02770903.2020.1759084⟩, Journal of Asthma, 2020, ⟨10.1080/02770903.2020.1759084⟩
- Accession number :
- edsair.doi.dedup.....d2585017cc3569b6fe9446d8316aaf4a
- Full Text :
- https://doi.org/10.1080/02770903.2020.1759084⟩